Spine

Innovasive™ Granted FDA Clearance for DualX™ Expanding Interbody Spinal Device

MISSION VIEJO, CALIF. (PRWEB) OCTOBER 31, 2018 Innovasive, a privately-held spinal device company, focuses on developing and commercializing minimally-invasive, innovative spinal technologies. Today, Innovasive announced that they have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market their DualX technology, a titanium, dual expanding, interbody device for spinal fusion procedures in the

By |2018-10-31T22:50:32+00:00October 31st, 2018|Regulatory, Spine|
Read More

Alphatec Announces Participation at Stifel 2018 Healthcare Conference

CARLSBAD, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced it will present at the Stifel 2018 Healthcare Conference on November 14, 2018, at 2:00

By |2018-10-31T17:32:36+00:00October 31st, 2018|Spine|
Read More

EOS imaging Announces Installations of First EOS® Systems in Spain and Portugal

October 30, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - SME), a pioneer in 2D/3D orthopedic medical imaging, today announced the first two installations in Barcelona at Clavel's Instituto, a spine center of Hospital Quiron, and the HM Delfos Hospital. In addition, the first installation in Portugal is

By |2018-10-30T20:19:21+00:00October 30th, 2018|Spine|
Read More

Life Spine Announces First Clinical Cases of PROLIFT® Post Pack Expandable TLIF/PLIF Spacer System

October 30, 2018 HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders today announced the first clinical cases of PROLIFT Post Pack Expandable Interbody System with Dr. Richard Weiner of Dallas, Texas and Dr. Bryan Barnes of Athens, Georgia. PROLIFT Post Pack

By |2018-10-30T16:45:34+00:00October 30th, 2018|Spine, Top Stories|
Read More

South Denver Surgery Center First to Deploy 7D Surgical’s Machine-Vision Image Guided Surgery (MvIGS) Platform in Colorado

TORONTO, Oct. 29, 2018 /PRNewswire/ -- As providers around the world look for new and innovative ways to improve surgical outcomes and patient safety, the South Denver Surgery Center has taken a leap into the future with the installation of the 7D Surgical System for spinal procedures.  This system virtually replaces standard fluoroscopy, providing the surgical team with

By |2018-10-30T16:18:10+00:00October 30th, 2018|Spine, Top Stories|
Read More

Camber Spine Announces Hitting $1M Milestone With SPIRA™-C In Less Than 6 Months

WAYNE, Pa., Oct. 25, 2018 /PRNewswire/ -- Camber Spine today announced reaching the $1 million milestone with their recently launched SPIRA™-C in less than 6 months. "The remarkable success and the early adoption of this revolutionary technology by so many surgeon users has attributed to this milestone," commented CEO, Daniel Pontecorvo. "Camber Spine is now following through on its promise to be

By |2018-10-25T17:02:45+00:00October 25th, 2018|Spine, Top Stories|
Read More

Aurora Spine Announces European Patent Related To ZIP Minimally Invasive Spinal Implant

CARLSBAD, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the grant by the European Patent Office (the “EPO”) of Aurora’s first European patent related to the ZIP®, minimally invasive spinal implant. The patent is titled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation

By |2018-10-25T16:32:21+00:00October 25th, 2018|Regulatory, Spine|
Read More

SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease

October 25, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced 12-month endpoint data from its Phase 1/Phase 2 clinical trial for treatment of degenerative disc disease (DDD). The analysis showed that patients who received intradiscal injections of the HDF

By |2018-10-25T15:55:30+00:00October 25th, 2018|Spine, Top Stories|
Read More

OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System

WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new RESPONSE 4.5/5.0mm System for treating smaller stature younger patients with complex scoliosis.  The system represents the

By |2018-10-19T15:53:09+00:00October 19th, 2018|Regulatory, Spine, Top Stories|
Read More

NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board

SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018. Mr. Barry will join the NuVasive Board of Directors; Mr. Lucier

By |2018-10-19T15:38:32+00:00October 19th, 2018|Spine|
Read More
Odysseus Medical Solutions 2018
RssEmail